Dipexium Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
Phase 3
Completed
- Conditions
- Diabetic Foot Infection
- Interventions
- First Posted Date
- 2012-05-09
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Dipexium Pharmaceuticals, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT01594762
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
Phase 3
Completed
- Conditions
- Diabetic Foot Infection
- Interventions
- First Posted Date
- 2012-05-03
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Dipexium Pharmaceuticals, Inc.
- Target Recruit Count
- 189
- Registration Number
- NCT01590758
© Copyright 2025. All Rights Reserved by MedPath